0000899243-21-003420.txt : 20210126
0000899243-21-003420.hdr.sgml : 20210126
20210126213325
ACCESSION NUMBER: 0000899243-21-003420
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210122
FILED AS OF DATE: 20210126
DATE AS OF CHANGE: 20210126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BELANOFF JOSEPH K
CENTRAL INDEX KEY: 0001286199
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 21556541
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC
CENTRAL INDEX KEY: 0001088856
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770487658
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650.688.8803
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-22
0
0001088856
CORCEPT THERAPEUTICS INC
CORT
0001286199
BELANOFF JOSEPH K
C/O CORCEPT THERAPEUTICS INCORPORATED
149 COMMONWEALTH DRIVE
MENLO PARK
CA
94025
1
1
0
0
Chief Executive Officer
Common Stock
2021-01-22
4
M
0
800000
4.42
A
3299214
D
Common Stock
2021-01-22
4
F
0
481088
28.06
D
2818126
D
Stock Option (Right to Buy)
4.42
2021-01-22
4
M
0
800000
0.00
D
2021-05-19
Common Stock
800000
0
D
These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on January 22, 2021. The options subject to the net exercise were to expire on May 19, 2021.
Fully exercisable.
/s/ G. Charles Robb, Attorney-in-Fact for Joseph K. Belanoff
2021-01-26